Table 2 Clinical and radiological characteristics of the study cohort

Age (years)

<60/ ≥60

212 (59.2)/146 (40.8)

Gender

Female / Male

142 (39.7) /216 (60.3)

WBC(× 10⁹/L)

<10/≥10

329 (91.9) /29 (8.1)

Neutrophil count(×10⁹/L)

<7/≥7

289 (80.7) /69 (19.3)

Lymphoeyte count(×10⁹/L)

<4/≥4

348 (97.2)/10 (2.8)

HGB(g/L)

<100/≥100

170 (47.5) /188 (52.5)

PLT(×10⁹/L)

<300/≥300

191 (53.4) /167 (46.6)

ALT(U/L)

<40/≥40

91 (25.4)/267 (74.6)

AST(U/L)

<45/≥45

96 (26.8) /262 (73.2)

ALB(g/L)

<35/≥35

70 (19.6) /288 (80.4)

TBIL (mmol/L)

<20.5/≥20.5

80 (22.3) /278 (77.7)

IBIL (mmol/L)

<15/≥15

182 (50.8) /176 (49.2)

CRP (mg/L)

<8/≥8

108 (30.2) /250 (69.8)

mGPS

0 / 1 / 2

222 (62.0) /87 (24.3) /49 (13.7)

CA19–9(U/ml)

<35/≥35

90 (25.1) /268 (74.9)

CEA (μg/L)

<5/≥5

261 (72.9) / 97 (27.1)

TNM

IA/IB/IIA/IIB/III

72 (20.1) / 93 (26.0) / 34 (9.5) /

104 (29.1) / 55 (15.4)

LN metastasis

absent/present

199 (55.6) /159 (44.4)

Tumor differentiation

high/ moderate / poor

7 (2.0) / 188 (52.5) / 163 (45.5)

NLR

≤3.32 />3.32

226 (63.1) /132 (36.9)

PLR

≤99.02/>99.02

31 (8.7) / 327 (91.3)

204 (57.0)/154 (43.0)

mGPS

0/1/2

222 (62.0) /87 (24.3) /49 (13.7)

PNI

0 / 1

277 (77.4) /81 (22.6)

PI

0 / 1 / 2

216 (60.3) / 119 (33.2) / 23 (6.4)

Chemotherapy

No / Yes

192 (53.6) / 166 (46.4)